Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Coping With Craving and Withdrawal Due to Substance Use Disorders During the COVID-19 Lockdown PDF $40.00
$40.00
× Placeholder Staging Treatment Intensity and Defining Resistant Depression: Historical Overview and Future Directions PDF $40.00
$40.00
× Placeholder The Adverse Effect Profile and Efficacy of Divalproex Sodium Compared With Valproic Acid: A Pharmacoepidemiology Study PDF $40.00
$40.00
× Placeholder Tic-Related Versus Tic-Free Obsessive-Compulsive Disorder: Clinical Picture and 2-Year Natural Course PDF $40.00
$40.00
× Placeholder Dawn Simulation Treatment of Abstinent Alcoholics With Winter Depression PDF $40.00
$40.00
× Placeholder Escitalopram Continuation Treatment Prevents Relapse of Depressive Episodes PDF $40.00
$40.00
× Placeholder Agomelatine Prevents Relapse in Generalized Anxiety Disorder: A 6-Month Randomized, Double-Blind, Placebo-Controlled Discontinuation Study PDF $40.00
$40.00
× Placeholder Childhood Separation Anxiety Disorder and Panic Disorder: Differences Between Respiratory and Nonrespiratory Subtypes PDF $40.00
$40.00
× Placeholder How Can We Use Depression Severity to Guide Treatment Selection When Measures of Depression Categorize Patients Differently? PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $360.00
Total $360.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe